Zeo Scientifix, INC. (ZEOX) — SEC Filings

Overview

Zeo Scientifix, INC. (ZEOX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 21, 2026: Zeo ScientifiX, Inc. filed an 8-K on April 21, 2026, reporting other events and financial statements. The filing includes an iXBRL 8-K document and exhibits, with the company's mailing and business address listed as 3321 College Avenue, Suite 246, Davie, FL 33314.

Sentiment Summary

Across 39 filings, the sentiment breakdown is: 2 bearish, 37 neutral. The dominant filing sentiment for Zeo Scientifix, INC. is neutral.

Filing Type Overview

Zeo Scientifix, INC. (ZEOX) has filed 27 8-K, 6 10-Q, 1 S-1/A, 1 S-1, 2 10-K, 1 8-K/A, 1 SC 13G with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (39)

• Zeo ScientifiX Files 8-K — 8-K · Apr 21, 2026 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on April 21, 2026, reporting other events and financial statements. The filing includes an iXBRL 8-K document and exhibits, wi
• Zeo ScientifiX Files 8-K with Exhibits — 8-K · Apr 9, 2026 Risk: medium
  Zeo ScientifiX, Inc. filed an 8-K on April 9, 2026, reporting other events and financial statements. The filing includes an exhibit (EX-99.1) and XBRL data, ind
• Zeo ScientifiX Files 8-K Report — 8-K · Apr 7, 2026 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K report on April 7, 2026, primarily detailing "Other Events" under Item 8.01 and including financial statements and exhibits un
• Zeo ScientifiX Files 8-K with Financials — 8-K · Mar 31, 2026 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on March 31, 2026, reporting other events and financial statements. The filing includes an iXBRL document and exhibits, with t
• 8-K Filing — 8-K · Dec 3, 2025
• Zeo ScientifiX Files 8-K — 8-K · Oct 23, 2025 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on October 23, 2025, reporting other events and financial statements. The company, formerly known as Organicell Regenerative M
• Zeo ScientifiX Losses Double Amid Soaring Expenses, Despite Revenue Growth — 10-Q · Sep 15, 2025 Risk: high
  Zeo ScientifiX, Inc. (ZEOX) reported a significant increase in net loss for the three months ended July 31, 2025, reaching $2,072,000, up from $1,012,000 in the
• Zeo ScientifiX Reports Unregistered Equity Sale — 8-K · Jul 29, 2025 Risk: medium
  Zeo ScientifiX, Inc. reported on July 25, 2025, an unregistered sale of equity securities. The company, formerly known as Organicell Regenerative Medicine, Inc.
• Zeo ScientifiX Appoints New CEO, CFO, COO — 8-K · Jul 21, 2025 Risk: medium
  Zeo ScientifiX, Inc. announced on July 18, 2025, a series of executive and board changes. Dr. David L. Smith has been appointed as the new Chief Executive Offic
• Zeo ScientifiX Files 8-K — 8-K · Jul 9, 2025 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on July 9, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organicell R
• Zeo ScientifiX Files 8-K — 8-K · Jun 24, 2025 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on June 24, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organicell
• Zeo ScientifiX Revenue Up, But Losses Widen to $2M — 10-Q · Jun 16, 2025 Risk: high
  Zeo ScientifiX, Inc. reported a net loss of $1,059,600 for the three months ended April 30, 2025, a significant increase from the net loss of $673,700 for the s
• Zeo ScientifiX Files S-1/A Update — S-1/A · May 16, 2025 Risk: medium
  Zeo ScientifiX, Inc. filed an S-1/A on May 16, 2025, to update its registration statement. The company, formerly known as Organicell Regenerative Medicine, Inc.
• Zeo ScientifiX Reports Equity Sales and Board Changes — 8-K · May 12, 2025 Risk: medium
  On May 8, 2025, Zeo ScientifiX, Inc. reported on two key events: unregistered sales of equity securities and changes in its board and officer compensation. The
• Zeo ScientifiX Announces Board and Officer Changes — 8-K · Apr 2, 2025 Risk: medium
  Zeo ScientifiX, Inc. announced on April 1, 2025, a change in its board of directors and the appointment of new officers. The company also reported on compensato
• Zeo ScientifiX Files S-1 for Public Offering — S-1 · Mar 26, 2025 Risk: medium
  Zeo ScientifiX, Inc. filed an S-1 form on March 26, 2025, to register its securities. The company, formerly known as Organicell Regenerative Medicine, Inc., is
• Zeo ScientifiX Files Q1 2025 10-Q — 10-Q · Mar 17, 2025 Risk: medium
  Zeo ScientifiX, Inc. filed its 10-Q for the period ending January 31, 2025. The company, formerly known as Organicell Regenerative Medicine, Inc., is in the bio
• Zeo ScientifiX Files 8-K with Financials and Exhibits — 8-K · Feb 18, 2025 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on February 18, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organic
• Zeo ScientifiX Files 8-K — 8-K · Feb 11, 2025 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on February 11, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organic
• Zeo ScientifiX, Inc. Files 8-K for Agreements and Officer Changes — 8-K · Feb 10, 2025 Risk: medium
  On February 4, 2025, Zeo ScientifiX, Inc. reported a material definitive agreement and changes in its officer and director positions. The company also filed fin
• 10-K Filing — 10-K · Jan 29, 2025
• Zeo ScientifiX Files 8-K with Corporate Updates — 8-K · Dec 19, 2024 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on December 19, 2024, reporting events as of December 17, 2024. The filing indicates amendments to its articles of incorporati
• Zeo ScientifiX Files 8-K/A Amendment — 8-K/A · Nov 22, 2024 Risk: low
  Zeo ScientifiX, Inc. filed an amendment (8-K/A) on November 22, 2024, to its Form 8-K originally reported on November 15, 2024. This amendment pertains to Regul
• Zeo ScientifiX Files 8-K with Financials — 8-K · Nov 15, 2024 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on November 15, 2024, reporting under Regulation FD and including financial statements and exhibits. The company, formerly kno
• Zeo ScientifiX Files 8-K — 8-K · Nov 13, 2024 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on November 13, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organic
• Zeo ScientifiX Files 8-K: Other Events & Exhibits — 8-K · Oct 15, 2024 Risk: medium
  Zeo ScientifiX, Inc. filed an 8-K on October 15, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organice
• Zeo ScientifiX Files 8-K Reporting Other Events — 8-K · Sep 30, 2024 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on September 30, 2024, reporting "Other Events." The company, formerly known as Organicell Regenerative Medicine, Inc., is inc
• Zeo ScientifiX Files 8-K: "Other Events" Reported — 8-K · Sep 20, 2024 Risk: medium
  Zeo ScientifiX, Inc. (formerly Organicell Regenerative Medicine, Inc.) filed an 8-K on September 20, 2024, reporting "Other Events." The filing does not contain
• Zeo ScientifiX Files 10-Q for July 2024 Period — 10-Q · Sep 16, 2024 Risk: medium
  Zeo ScientifiX, Inc. filed its 10-Q for the period ending July 31, 2024. The company, formerly known as Organicell Regenerative Medicine, Inc., is in the biolog
• SC 13G Filing — SC 13G · Aug 12, 2024
• Zeo ScientifiX Names New CMO, Reports Equity Sales — 8-K · Aug 7, 2024 Risk: medium
  Zeo ScientifiX, Inc. announced on July 11, 2024, the resignation of Dr. Robert J. Simon as Chief Medical Officer and the appointment of Dr. David L. Smith as th
• Zeo ScientifiX Files 8-K for Equity Sale — 8-K · Jul 12, 2024 Risk: medium
  On July 8, 2024, Zeo ScientifiX, Inc. reported an unregistered sale of equity securities. The company issued 1,000,000 shares of common stock at a purchase pric
• Zeo ScientifiX Files Q2 10-Q — 10-Q · Jun 14, 2024 Risk: medium
  Zeo ScientifiX, Inc. filed its 10-Q for the period ending April 30, 2024. The company, formerly known as Organicell Regenerative Medicine, Inc., is in the biolo
• Zeo ScientifiX Appoints New Directors, Board Shakeup — 8-K · Jun 3, 2024 Risk: low
  Zeo ScientifiX, Inc. announced on May 31, 2024, a change in its board of directors. The company elected two new directors, Mr. David L. Smith and Mr. Robert J.
• Zeo ScientifiX Appoints New CEO and CMO — 8-K · Apr 2, 2024 Risk: medium
  Zeo ScientifiX, Inc. announced on April 1, 2024, a significant change in its leadership and board composition. Dr. David L. Smith has been appointed as the new
• Zeo ScientifiX, Inc. Files 10-Q for Period Ending January 31, 2024 — 10-Q · Mar 18, 2024 Risk: medium
  Zeo ScientifiX, Inc. (ZEOX) filed a Quarterly Report (10-Q) with the SEC on March 18, 2024. Zeo ScientifiX, Inc. filed a 10-Q for the period ending January 31,
• Zeo ScientifiX Files 8-K — 8-K · Mar 4, 2024 Risk: low
  Zeo ScientifiX, Inc. filed an 8-K on March 4, 2024, reporting other events and financial statements. The company, formerly known as Organicell Regenerative Medi
• Zeo ScientifiX Amends Bylaws, Fiscal Year — 8-K · Feb 26, 2024 Risk: medium
  Zeo ScientifiX, Inc. (formerly Organicell Regenerative Medicine, Inc.) filed an 8-K on February 26, 2024, reporting an event on February 20, 2024, related to am
• Organicell Regenerative Medicine, Inc. Files 2023 10-K Report — 10-K · Jan 29, 2024 Risk: low
  Organicell Regenerative Medicine, Inc. (ZEOX) filed a Annual Report (10-K) with the SEC on January 29, 2024. Organicell Regenerative Medicine, Inc. filed its an

Frequently Asked Questions